XML 16 R6.htm IDEA: XBRL DOCUMENT v3.22.4
Condensed Consolidated Statements of Shareholders' Equity (Unaudited) - USD ($)
Preferred Stock [Member]
Common Stock [Member]
Additional Paid-in Capital [Member]
Retained Earnings [Member]
Total
Beginning balance, value at Mar. 31, 2021 $ 13,013 $ 20,150,716 $ (12,254,191) $ 7,909,538
Beginning balance, shares at Mar. 31, 2021 1,301,358      
Net income (loss) 1,999,655 1,999,655
Issuance of common stock - non-employee   $ 17 16,983 17,000
Issuance of common stock - non-employee, shares   1,667      
Employee compensation-stock option   12,727 12,727
Exercise of stock options   $ 27 17,622 17,649
Exercise of stock options, shares   2,667      
Issuance of stock   $ 5,500 4,944,500 4,950,000
Issuance of stock, shares   550,000      
Payment of stock issuance expenses   (831,087) (831,087)
Issuance of common stock - directors   $ 6 4,994 5,000
Issuance of common stock - directors, shares   575      
Issuance of pre-funded warrants   4,881,667 4,881,667
Issuance of stock for stock issuance expenses   $ 190 (190)
Issuance of stock for stock issuance expenses, shares 19,047      
Redemption and retirement of treasury shares   $ (6,541) (4,301,149) (2,854,762) (7,162,452)
Redemption and retirement of treasury shares, shares   (654,105)      
Ending balance, value at Dec. 31, 2021 $ 12,212 24,896,783 (13,109,298) 11,799,697
Ending balance, shares at Dec. 31, 2021 1,221,209      
Beginning balance, value at Sep. 30, 2021 $ 12,192 24,883,954 (14,535,193) 10,360,953
Beginning balance, shares at Sep. 30, 2021 1,219,209      
Net income (loss) 1,425,895 1,425,895
Employee compensation-stock option   3,649 3,649
Exercise of stock options   $ 20 9,180 9,200
Exercise of stock options, shares 2,000      
Ending balance, value at Dec. 31, 2021 $ 12,212 24,896,783 (13,109,298) 11,799,697
Ending balance, shares at Dec. 31, 2021 1,221,209      
Beginning balance, value at Mar. 31, 2022 $ 12,212 24,902,694 (14,878,482) 10,036,424
Beginning balance, shares at Mar. 31, 2022 1,221,209      
Net income (loss) (1,652,902) (1,652,902)
Exercise of common stock warrants   $ 3,484 972,054 975,538
Exercise of common stock warrants, shares 348,406      
Issuance of common stock - officers   $ 33 31,216 31,249
Issuance of common stock - officers, shares   3,335      
Issuance of common stock - non-employee   $ 100 93,600 93,700
Issuance of common stock - non-employee, shares   10,000      
Employee compensation-stock option   162,686 162,686
Issuance of stock   $ 10,000 3,990,000 4,000,000
Issuance of stock, shares   1,000,000      
Payment of stock issuance expenses   (637,250) (637,250)
Exercise of pre-funded warrants   $ 5,611 162,723 168,334
Exercise of pre-funded warrants, shares   561,113      
Issuance of common stock - directors   $ 25 19,991 20,016
Issuance of common stock - directors, shares   2,468      
Rounding of common stock issued due to reverse split   $ 17 (17)
Rounding of common stock issued due to reverse split, shares   1,688      
Ending balance, value at Dec. 31, 2022 $ 31,482 29,697,697 (16,531,384) 13,197,795
Ending balance, shares at Dec. 31, 2022 3,148,219      
Beginning balance, value at Sep. 30, 2022 $ 31,088 29,511,318 (14,598,018) 14,944,388
Beginning balance, shares at Sep. 30, 2022 3,108,814      
Net income (loss) (1,933,366) (1,933,366)
Exercise of common stock warrants   $ 394 109,941 110,335
Exercise of common stock warrants, shares 39,405      
Issuance of common stock - officers      
Issuance of common stock - non-employee      
Employee compensation-stock option     76,438 76,438
Ending balance, value at Dec. 31, 2022 $ 31,482 $ 29,697,697 $ (16,531,384) $ 13,197,795
Ending balance, shares at Dec. 31, 2022 3,148,219